Drug rash with eosinophilia and systemic symptoms complicated by haemophagocytic lymphohistiocytosis: is screening required?

2021 ◽  
Author(s):  
K. Hussain ◽  
S. Zaheri ◽  
N. P. Patel
Keyword(s):  
Haemophagocytic Lymphohistiocytosis ◽  
Drug Rash ◽  
Systemic Symptoms

scholarly journals Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Due to Streptomycin

2003 ◽  
Vol 84 (1) ◽  
pp. 92-94 ◽  
Author(s):  
Thierry Passeron ◽  
Mamadou Cissé Ndir ◽  
Cécile Aubron ◽  
Philippe Hovette
Keyword(s):  
Drug Rash ◽  
Systemic Symptoms

A Recurrent Drug Rash with Eosinophilia and Systemic Symptoms

2007 ◽  
Vol 24 (6) ◽  
pp. 666-668 ◽  
Author(s):  
SHAKER BEN SALEM ◽  
RAOUDHA SLIM ◽  
MOHAMED DENGUEZLI ◽  
RAFIA NOUIRA ◽  
HOUSSEM HMOUDA ◽  
...  
Keyword(s):  
Drug Rash ◽  
Systemic Symptoms

Could Anti-Tuberculous Medications Be Causes Of Drug Rash With Eosinophilia And Systemic Symptoms Syndrome?

2011 ◽  
Author(s):  
SANG-HA KIM ◽  
Shun Nyung Lee ◽  
Seok Jeong Lee ◽  
Myoung Kyu Lee ◽  
Won Yeon Lee ◽  
...  
Keyword(s):  
Drug Rash ◽  
Systemic Symptoms

P0264 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS SYNDROME INDUCED BY SULFASALAZINE

2009 ◽  
Vol 20 ◽  
pp. S92-S93
Author(s):  
Gulistan Bahat ◽  
Hulya Gamze Celik ◽  
Bulent Saka ◽  
Fatih Tufan ◽  
Cemil Tascioglu
Keyword(s):  
Drug Rash ◽  
Systemic Symptoms

Drug rash with eosinophilia and systemic symptoms induced by cefotaxime and ampicillin

2008 ◽  
Vol 50 (3) ◽  
pp. 406-408 ◽  
Author(s):  
Takehisa Fujiwaki ◽  
Tetsushi Yoshikawa ◽  
Reiko Urashima ◽  
Chihiro Ishioka
Keyword(s):  
Drug Rash ◽  
Systemic Symptoms

scholarly journals Therapeutic Trial of Rifabutin After Rifampicin-Associated DRESS Syndrome in Tuberculosis-Human Immunodeficiency Virus Coinfected Patients

2016 ◽  
Vol 3 (3) ◽  
Author(s):  
Rannakoe J. Lehloenya ◽  
Sipho Dlamini ◽  
Rudzani Muloiwa ◽  
Betty Kakande ◽  
Mzudumile R. Ngwanya ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
Clinical Management ◽  
Cross Reactivity ◽  
Therapeutic Trial ◽  
Drug Reactions ◽  
Dress Syndrome ◽  
Drug Eruptions ◽  
Immunodeficiency Virus ◽  
Drug Rash ◽  
Systemic Symptoms

Abstract Elimination of a rifamycin from the treatment regimen for tuberculosis negatively impacts outcomes. Cross-reactivity between the rifamycins after drug eruptions is unclear. We report 6 consecutive human immunodeficiency virus-infected patients with rifampicin-associated drug rash with eosinophilia and systemic symptoms (DRESS) syndrome confirmed on diagnostic rechallenge. The patients subsequently tolerated rifabutin. These data inform clinical management of tuberculosis-associated drug reactions.

Sign in / Sign up

Export Citation Format

Share Document